Marimed (MRMD) Dividends Paid - Common Growth (3y) (2020 - 2026)
Marimed (MRMD) Dividends Paid - Common Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.60 Bn | 87.73 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.16 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.46 Bn | 30.52 Bn | 1.62 Bn | 8.78% |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | -1.77% |
| 5 | United Therapeutics | 23.13 Bn | 20.98 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn | -0.98% |
| 8 | Neurocrine Biosciences | 17.75 Bn | 16.43 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.60 Bn | 12.18 Bn | 785.00 Mn | - |
| 10 | Marimed | 25.72 Mn | 17.78 Mn | 15.28 Mn | 12.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.96% |
| Dec 31, 2025 | -76.86% |
| Sep 30, 2025 | -60.31% |
| Jun 30, 2025 | -71.12% |
| Mar 31, 2025 | -16.88% |
| Dec 31, 2024 | 27.30% |
| Sep 30, 2024 | -56.44% |
| Jun 30, 2024 | -68.09% |
| Mar 31, 2024 | -18.46% |
| Dec 31, 2023 | -27.77% |
| Sep 30, 2023 | -9.00% |
| Jun 30, 2023 | -10.72% |
| Mar 31, 2023 | -30.41% |
| Dec 31, 2022 | 163.35% |
| Sep 30, 2022 | -20.51% |
| Jun 30, 2022 | -12.70% |
| Mar 31, 2022 | -16.36% |
| Dec 31, 2021 | -53.84% |
| Sep 30, 2021 | -13.39% |
| Jun 30, 2021 | -27.42% |